Stock Trend Analysis Report
Prepared for you on Friday, December 1, 2023.
Regen Biopharma, Inc. Common (NASDAQ:RGBP)
Long-Term Downtrend (-90) - RGBP is in a strong downtrend that is likely to continue. While RGBP is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid RGBP?
MarketClub looks at technical strength and momentum to determine if the timing is right for RGBP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for RGBP
The long-term trend has been DOWN since Nov 9th, 2022 at 0.0051
The intermediate-term trend has been DOWN since Nov 8th, 2023 at 1.5300
The short-term trend has been DOWN since Nov 30th, 2023 at 1.2800
Smart Scan Analysis for RGBP
Based on our trend formula, RGBP is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||0.07||Year High Date||2018-02-09|
|Year Low||0.0031||Year Low Date||2018-11-23|
|52wk High||9||52wk High Date||2022-11-30|
|52wk Low||1.03||52wk Low Date||2023-07-24|
|Average Volume||13,555||Shares Outstanding||3,559|